Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Neurotech adds members to board, appoints CMO

This article was originally published in Scrip

Executive Summary

Neurotech Pharmaceuticals, which is developing treatments for chronic retinal diseases, has named Dr Eugene de Juan and Dr Lester Kaplan to its board of directors. In addition, former Allergan vice-president and head of opthmology Dr Rhett Schiffman has joined Neurotech as chief medical officer. Dr de Juan is a retinal surgeon, inventor and entrepreneur; he is currently vice-chair of ForSight Labs. Meanwhile, Dr Kaplan was previously executive VP and president, research & development, and a board member of Allergan.

Related Companies




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts